Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. The ‘Cents’ Behind Clinical Trials and Health Research

The ‘Cents’ Behind Clinical Trials and Health Research

Stories Dec 2, 2013 2 minutes

Clinical trials for viral hepatitis puts money into B.C.’s economy and saves health care dollars.

While the goal of a clinical trial is ultimately to unlock the potential of new therapies and treatments that will result in improved quality of lives and lives saved, the additional economic benefits of such programs are substantial and shouldn’t be overlooked.

“The economic benefit of clinical trials to B.C.’s economy is huge,” says Dr. Eric Yoshida, head of gastroenterology at Vancouver General Hospital (VGH) and director of the BC Hepatitis Program. “The enterprise of running a clinical trial or program means jobs are created, salaries are paid, needed equipment and materials are bought for labs, tests such as ultrasounds and biopsies are covered, overhead is partly paid for at research locations, and millions of dollars are generated into the provincial economy.”

Health research contributes approximately $150 million annually to the provincial Gross Domestic Product (GDP) and creates close to 2,500 direct and indirect employment opportunities in BC1. VCH Research Institute is a major player in BC’s health research industry. It is home to seven renowned research centres and many clinical trial teams, including the BC Hepatitis Program clinical research team.

“Our team at VGH has been involved in every single major clinical trial for hepatitis C drugs since 2002,” says Dr. Yoshida. “We’re considered one of the leading sites in Canada and we’re the only centre in this field that is within the UBC domain.”

The health care savings resulting from viral hepatitis clinical trials have also proven significant. Many patients in previous trials have received highly effective therapies free of charge before the drugs are officially licensed for the general population.

Dr. Yoshida estimates that every patient cured through a clinical trial has saved the ministry between $50-$100 thousand dollars.

“We treat and cure patients through trials with exceptional, effective therapies that they wouldn’t have had access to for a long time,” says Dr. Yoshida. “In so doing, we’re preventing cirrhosis, future transplants, and liver cancer – these are major, costly, health problems being prevented.”

 

1BC Clinical Research Infrastructure Network (BCCRIN) Report - Economic Impacts of Clinical Research in British Columbia, March 6, 2013

 

Researchers

Eric Yoshida

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy